Carberry Christine A.
Chief Operating Officer at KERYX BIOPHARMACEUTICALS INC
- Sold, on record
- $103k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 11, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KERYX BIOPHARMACEUTICALS INCChief Operating Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KERYX BIOPHARMACEUTICALS INCPlan not statedJan 18, 2018 2018
Sold 9,048 shares at $4.87 ($44k)
Carberry Christine A., Chief Operating Officer
Sold 10.6% of holdings ($414k position)75,952 shares leftFirst sale on recordFiling
- 2 Form 4 sale KERYX BIOPHARMACEUTICALS INCPlan not statedApr 18, 2018 +90 days
Sold 2,026 shares at $4.83 ($10k)
Carberry Christine A., Chief Operating Officer
Sold 1.7% of holdings ($566k position)115,176 shares leftFiling
- 3 Form 4 sale KERYX BIOPHARMACEUTICALS INCPlan not statedJul 18, 2018 +91 days
Sold 2,021 shares at $4.49 ($9k)
Carberry Christine A., Chief Operating Officer
Sold 1.8% of holdings ($517k position)113,155 shares leftFiling
- 4 Form 4 sale KERYX BIOPHARMACEUTICALS INCPlan not statedOct 18, 2018 +92 days
Sold 2,040 shares at $3.29 ($7k)
Carberry Christine A., Chief Operating Officer
Sold 1.8% of holdings ($372k position)111,115 shares left1x usual sizeFiling
- 5 Form 4 sale KERYX BIOPHARMACEUTICALS INCUnusualDec 11, 2018 +54 days
Sold 10,469 shares at $3.22 ($34k)
Carberry Christine A., Chief Operating Officer
Sold 9.4% of holdings ($358k position)100,646 shares left5.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2018 | Dec 13, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 10,469 | $34k | 9.4% | Unusual | SEC |
| Oct 18, 2018 | Oct 22, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,040 | $7k | 1.8% | Plan not stated | SEC |
| Jul 18, 2018 | Jul 19, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,021 | $9k | 1.8% | Plan not stated | SEC |
| Apr 18, 2018 | Apr 20, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,026 | $10k | 1.7% | Plan not stated | SEC |
| Jan 18, 2018 | Jan 22, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 9,048 | $44k | 10.6% | Plan not stated | SEC |